Charts & intelligence
Fundamentals
Financials
Activity
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition
Repligen to buy cell therapy maker BioLife in $1.5 billion deal